Experimental evidence demonstrates antitumor effects of Fer-Ti-1 via photodynamic therapy and immune modulation, indicating a new cancer treatment approach.
We present a ferrocene-functionalized phenolato TiIV complex stabilized by dipicolinic acid (Fer-Ti-1) as a nonheavy-metal photosensitizer for photodynamic therapy (PDT), integrating photoactivation with immune modulation. Fer-Ti-1 is highly stable in aqueous solutions, exhibiting strong visible-light absorption from ligand-to-metal and metal-to-metal charge-transfer transitions. Upon 560 nm irradiation, Fer-Ti-1 undergoes in situ transformation to a TiIII bis-dipicolinic acid species, leading to efficient hydroxyl-radical generation and potent photocytotoxicity against multiple tumor cell lines, while remaining nontoxic in the dark and to normal AML12 cells. Detailed uptake and organelle profiling reveal rapid internalization and preferential mitochondrial accumulation, inducing mitochondrial depolarization and dual programmed cell death, predominantly ferroptosis and apoptosis. Photoactivated Fer-Ti-1 also triggers mitochondrial DNA leakage and activates the cGAS-STING pathway, driving immunogenic cell death, dendritic-cell maturation, and enhanced T-cell responses. In Hep G2 xenografts, Fer-Ti-1 plus light achieves strong tumor suppression with favorable safety, establishing a biocompatible Ti-based PDT and immunotherapy platform.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: